New Jersey Municipal Cannabis Control: Local Authority and Licensing

Executive Summary

New Jersey grants municipalities extraordinary control over cannabis operations within their borders, creating a patchwork of local regulations that determine where dispensaries, cultivation facilities, and consumption lounges can operate. Since the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA) took effect on February 22, 2021, New Jersey's 565 municipalities have wielded opt-in authority, public hearing requirements, and zoning powers that shape the state's $1.8 billion adult-use market. Unlike states with preemptive frameworks, New Jersey embedded municipal consent into N.J.S.A. 24:6I-45, requiring local ordinances before any cannabis business can open. As of May 2026, approximately 280 municipalities permit some form of cannabis activity, while 285 maintain prohibition through inaction or explicit bans. This municipal control extends to operational details including buffer zones from schools, operating hours, and density restrictions—powers that create vastly different business environments across county lines and generate ongoing litigation over procedural fairness, equal protection, and the scope of home rule authority.

Why Municipal Control Matters

The municipal opt-in framework determines market access for operators, tax revenue for towns, and patient access for 135,000 registered medical marijuana users plus millions of adult-use consumers. A dispensary approved in Jersey City faces entirely different regulations than one proposed in Ocean County, where most municipalities remain closed. This fragmentation affects capital deployment—multi-state operators prioritize municipalities with clear approval pathways, leaving rural and conservative towns without access. The stakes are measured in millions: municipalities that opt in collect a 2% local transfer tax on retail sales, generating $500,000 to $2 million annually for mid-sized towns with active dispensaries. Conversely, municipalities that ban cannabis see residents drive to neighboring towns, exporting tax revenue and creating enforcement challenges.

For patients, municipal bans create access deserts. Residents of municipalities without dispensaries travel an average of 18 miles to reach legal cannabis, according to New Jersey Cannabis Regulatory Commission data from March 2026. This disproportionately impacts low-income patients, elderly residents without transportation, and individuals in South Jersey, where municipal approval rates lag North Jersey by 22 percentage points. The municipal hearing process itself—the focus of recent advocacy and legal challenges—determines whether communities hear from patients, business owners, and opponents before councils vote, making procedural fairness a civil rights issue for access advocates.

Background and History: From Prohibition to Home Rule

The 2020 Referendum and CREAMMA's Passage

New Jersey voters approved adult-use cannabis legalization on November 3, 2020, with 67% support in a statewide referendum amending the state constitution. Public Question 1 added Article I, Paragraph 25 to the New Jersey Constitution, legalizing cannabis for adults 21 and older and directing the Legislature to establish a regulatory framework. The Legislature responded by enacting the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (A21/S21) on February 22, 2021, signed by Governor Phil Murphy after months of negotiation over social equity provisions, tax rates, and—critically—municipal authority.

The municipal opt-in provision emerged from legislative compromise. Home-rule advocates, including the New Jersey League of Municipalities, demanded local control as a condition of support. Progressive legislators sought statewide access to prevent wealthy suburbs from excluding dispensaries while profiting from decriminalization. The final text of N.J.S.A. 24:6I-45 split the difference: municipalities could prohibit cannabis businesses through ordinance or inaction, but could not ban personal possession or home cultivation (up to six plants for personal use, though home cultivation regulations remained unimplemented as of May 2026). The statute required municipalities to act affirmatively through ordinance to permit cannabis operations, defaulting to prohibition in the absence of local action.

The August 2021 Opt-In Deadline and Initial Wave

CREAMMA established an initial 180-day window ending August 21, 2021, during which municipalities could pass ordinances without triggering a referendum requirement. After that deadline, citizen petitions could force a public vote on any cannabis ordinance, raising the political stakes for councils. This deadline created urgency: by August 2021, 123 municipalities had passed enabling ordinances, concentrated in North Jersey urban centers, college towns, and shore communities seeking seasonal revenue. Jersey City, Hoboken, Montclair, Asbury Park, and Newark were among the early adopters.

Simultaneously, 187 municipalities passed explicit bans during the same window, particularly in Ocean County, Sussex County, and conservative suburban areas of Morris County and Bergen County. The remaining 255 municipalities took no action, defaulting to prohibition but preserving the option to opt in later without referendum risk. This three-way split—opt-in, explicit ban, inaction—defined the initial landscape and set the stage for ongoing municipal debates.

The Cannabis Regulatory Commission's Municipal Guidance

The New Jersey Cannabis Regulatory Commission (NJCRC), established under CREAMMA and chaired by Dianna Houenou (appointed April 2021), issued guidance on municipal authority in September 2021. The NJCRC clarified that municipalities could regulate "the manner" of cannabis operations through zoning, buffer zones, and operational requirements, but could not impose additional licensing requirements or fees beyond the state's application process. This guidance, formalized in N.J.A.C. 17:30-7.2, attempted to balance home rule with statewide regulatory consistency.

The Commission also established a municipal toolkit providing model ordinances, public hearing templates, and tax collection procedures. However, the toolkit's recommendations were non-binding, and municipalities diverged widely in implementation. Some towns adopted the model language verbatim; others crafted bespoke regulations imposing 1,000-foot buffers from schools (double the 500-foot state minimum), limiting dispensaries to industrial zones, or capping the number of licenses at one or two regardless of population.

Litigation and Legal Challenges (2022-2024)

Municipal cannabis control generated litigation on multiple fronts. In Green Thumb Industries v. Borough of Paramus (2022), a dispensary applicant challenged Paramus's refusal to hold a public hearing on a proposed ordinance, arguing that the council's closed-door rejection violated the Open Public Meetings Act (N.J.S.A. 10:4-6). The Bergen County Superior Court ruled in favor of Green Thumb in July 2022, holding that municipalities must provide a public hearing before rejecting cannabis ordinances if any formal consideration occurs. The decision, though not binding statewide, influenced subsequent municipal practices.

In ACLU-NJ v. Township of Lakewood (2023), civil rights advocates challenged Lakewood's ban as discriminatory, arguing it disproportionately harmed minority residents who comprised 40% of the township's cannabis arrests pre-legalization but had no legal access post-legalization. The Ocean County Superior Court dismissed the claim in March 2023, holding that CREAMMA's opt-in framework explicitly authorized municipal bans and that disparate impact alone did not constitute equal protection violation absent evidence of discriminatory intent. The ruling underscored the breadth of municipal authority under New Jersey's home rule tradition.

The 2024-2025 Second Wave of Opt-Ins

As early-adopting municipalities reported tax revenue windfalls—Jersey City collected $4.2 million in local cannabis taxes in fiscal year 2024—neighboring towns reconsidered their positions. Between January 2024 and December 2025, an additional 157 municipalities passed enabling ordinances, bringing the total to approximately 280 as of May 2026. This second wave included suburban towns in Middlesex County, Monmouth County shore communities, and several South Jersey municipalities in Camden County and Gloucester County.

The second wave also saw increased sophistication in municipal regulations. Towns imposed annual license renewal fees (typically $5,000-$10,000), mandatory community benefit agreements requiring operators to fund youth programs or infrastructure, and performance bonds. Some municipalities, including Princeton and Maplewood, established social equity preferences in local approval processes, awarding points to applicants with ownership by impact-zone residents or commitments to hire locally.

The May 2026 Municipal Hearing Debate

The triggering news from May 19, 2026, highlights renewed focus on municipal hearing procedures. Advocacy groups including the New Jersey CannaBusiness Association and the Coalition for Medical Marijuana-New Jersey have pushed for standardized hearing requirements, arguing that inconsistent public comment periods—ranging from 3 minutes to 15 minutes per speaker, and from single hearings to multi-meeting processes—create unequal access to the approval process. Some municipalities have conducted hearings with as few as 48 hours' public notice, while others have required 30-day comment periods. This procedural variation has become a flashpoint as the market matures and competition for limited municipal approvals intensifies.

Key Players in New Jersey's Municipal Cannabis Framework

New Jersey Cannabis Regulatory Commission

The NJCRC, led by Executive Director Jeff Brown since January 2022, oversees state-level licensing but lacks authority to override municipal bans or compel local approval. The Commission's five members, appointed by the Governor and legislative leaders, issue cultivation, manufacturing, distribution, and retail licenses—but only after applicants secure municipal approval. As of May 2026, the NJCRC had issued 187 retail licenses, 89 cultivation licenses, and 52 manufacturing licenses, but approximately 60 approved applicants remained unable to open due to pending municipal approvals or zoning disputes. The Commission has advocated for legislative reforms to streamline municipal processes but has no enforcement mechanism to compel local action.

New Jersey League of Municipalities

The League, representing all 565 municipalities, has defended local control as essential to New Jersey's home rule tradition. Executive Director Michael Cerra has testified before legislative committees that municipalities are best positioned to determine appropriate zoning, density, and operational requirements based on local character and infrastructure. The League opposed 2024 legislative proposals to establish a state-level appeals process for denied applications, arguing it would undermine the opt-in framework negotiated during CREAMMA's passage. The League publishes quarterly guidance on cannabis regulation and hosts an annual conference session on municipal best practices.

New Jersey CannaBusiness Association

The NJCBA, founded in 2018 and representing over 200 cannabis businesses, has pushed for municipal hearing standardization and limits on local fees. President Edmund DeVeaux has called for amendments to N.J.S.A. 24:6I-45 requiring municipalities to act on applications within 90 days and prohibiting denials without written findings. The NJCBA commissioned a 2025 study finding that municipal approval processes averaged 11 months from application to final vote, with some stretching beyond 18 months due to repeated hearings and zoning board appeals. The association has proposed model legislation establishing a "deemed approved" provision if municipalities fail to act within statutory timeframes.

Coalition for Medical Marijuana-New Jersey

Patient advocacy groups, led by the Coalition for Medical Marijuana-New Jersey, have focused on access equity. The Coalition's 2025 report documented that 40% of New Jersey's population lives in municipalities without dispensaries, forcing patients to travel or rely on delivery services (which face their own municipal restrictions). The Coalition has supported legislation to prohibit municipalities from banning medical dispensaries while allowing adult-use bans, arguing that patient access is a healthcare issue distinct from recreational commerce. This proposal has not advanced in the Legislature as of May 2026.

Multi-State Operators and Local Independents

Major MSOs including Curaleaf, Verano, and Ascend Wellness Holdings have navigated municipal control by concentrating applications in friendly jurisdictions and funding local advocacy campaigns. Curaleaf operates dispensaries in Bellmawr, Bordentown, and Edgewater Park—all early opt-in municipalities with streamlined approval processes. In contrast, smaller New Jersey-based operators have struggled with the resource intensity of municipal campaigns, particularly in towns requiring community outreach, traffic studies, and legal representation at multiple hearings. The average cost of securing municipal approval, including legal fees, consulting, and community engagement, ranges from $75,000 to $200,000, according to industry estimates compiled by the NJCBA in 2025.

Legal and Regulatory Framework

Statutory Foundation: N.J.S.A. 24:6I-45

N.J.S.A. 24:6I-45 grants municipalities authority to "adopt an ordinance to prohibit the operation of any one or more classes of cannabis establishments or cannabis distributors or cannabis delivery services" within their borders. The statute's opt-in structure means that absent a permissive ordinance, no cannabis business can operate, regardless of state licensure. The statute explicitly preserves municipal zoning authority under N.J.S.A. 40:55D-1 et seq., allowing towns to designate permissible zones, impose buffer requirements, and regulate hours of operation.

Critically, the statute prohibits municipalities from banning personal possession or consumption in private residences, and from imposing local taxes exceeding the 2% transfer tax authorized under N.J.S.A. 24:6I-36. Municipalities may not require separate local licenses or impose application fees beyond reasonable administrative costs. These limitations aim to prevent municipalities from creating de facto bans through excessive regulation.

Home Rule and the Faulkner Act

New Jersey's strong home rule tradition, rooted in the state constitution's Article IV, Section VII, Paragraph 11, grants municipalities broad police powers over local affairs. Most New Jersey municipalities operate under the Faulkner Act (N.J.S.A. 40:69A-1 et seq.), which provides various forms of government but consistently reserves zoning and land use authority to local control. Courts have consistently upheld municipal cannabis bans as valid exercises of home rule, absent evidence of discriminatory intent or conflict with state law.

Administrative Code: N.J.A.C. 17:30-7.2

The NJCRC's administrative rules at N.J.A.C. 17:30-7.2 require applicants to submit proof of municipal approval before the Commission will issue a final license. The rules specify that municipal approval must be "in the form of an ordinance, resolution, or letter from the municipal clerk" and must identify the specific location approved for operation. This requirement has generated disputes when municipalities issue conditional approvals subject to site plan review or zoning board variances, leaving applicants in limbo between state and local processes.

Open Public Meetings Act and Hearing Requirements

Municipal hearings on cannabis ordinances must comply with the Open Public Meetings Act (N.J.S.A. 10:4-6), requiring 48 hours' advance notice for regular meetings and public access to deliberations. However, the Act does not specify public comment procedures, duration, or the scope of issues councils must consider. This gap has allowed wide variation: some municipalities limit comment to zoning and traffic concerns, while others permit testimony on social equity, criminal justice, and public health. The absence of standardized hearing procedures has become a central advocacy issue as of May 2026.

State-by-State Breakdown: New Jersey's County-Level Patterns

Bergen County

Bergen County, New Jersey's most populous county with 955,000 residents, has a 32% municipal opt-in rate, with 22 of 70 municipalities permitting cannabis operations as of May 2026. Opt-in municipalities include Edgewater, Fort Lee, Hackensack, and Teaneck, concentrated along the Hudson River corridor and Route 4. Conservative suburban towns including Paramus, Ridgewood, and Franklin Lakes maintain explicit bans. The county's proximity to New York City has driven high retail demand, with Bergen County dispensaries reporting average monthly sales of $1.2 million as of Q1 2026.

Ocean County

Ocean County represents the opposite extreme: only 7 of 33 municipalities permit cannabis operations, a 21% opt-in rate. Lakewood, Toms River, and Brick Township—the county's three largest municipalities—maintain bans, creating access challenges for the county's 637,000 residents. The county's conservative political culture and high proportion of retiree residents have driven opposition. Ocean County residents travel an average of 26 miles to reach the nearest dispensary, typically in Monmouth County or Burlington County, according to NJCRC data.

Hudson County

Hudson County leads the state with a 75% opt-in rate: 9 of 12 municipalities permit cannabis operations, including Jersey City, Hoboken, Union City, and Weehawken. The county's urban density, progressive politics, and proximity to New York have made it a cannabis hub. Jersey City alone hosts 14 dispensaries as of May 2026, more than any other municipality in the state. Hudson County collected $8.9 million in local cannabis transfer taxes in fiscal year 2025, representing 22% of statewide municipal cannabis revenue.

Camden County

Camden County's opt-in rate stands at 48%, with 18 of 37 municipalities permitting operations. The city of Camden, Bellmawr, Gloucester City, and Pennsauken have emerged as South Jersey cannabis centers. The county's opt-in municipalities have prioritized social equity, with Camden requiring 50% of dispensary ownership to be held by impact-zone residents or individuals with prior cannabis convictions. This requirement, the strictest in the state, has slowed licensing but generated national attention as a model for reparative cannabis policy.

Monmouth County

Monmouth County's 53 municipalities show a 45% opt-in rate, with coastal towns including Asbury Park, Long Branch, and Neptune leading adoption. The county's seasonal tourism economy has driven interest in cannabis retail, with shore towns viewing dispensaries as revenue sources during summer months. However, inland suburban towns including Rumson, Colts Neck, and Holmdel maintain bans, creating a coastal-inland divide in access.

Market and Business Implications

Capital Allocation and Site Selection

Municipal control directly shapes capital deployment in New Jersey's cannabis market, with operators prioritizing municipalities offering streamlined approval processes and favorable zoning. Multi-state operators conduct municipal risk assessments scoring towns on political composition, approval timelines, and regulatory predictability. Jersey City, Hoboken, and Newark receive premium valuations for real estate due to their established approval pathways, while properties in municipalities without enabling ordinances trade at discounts of 40-60% compared to similar properties in opt-in towns.

The municipal approval bottleneck has concentrated market power. As of May 2026, 15 municipalities host 5 or more dispensaries each, accounting for 62% of the state's 187 licensed retail locations. This concentration creates competitive advantages for early entrants and raises barriers for new applicants, who face saturated markets in friendly municipalities and closed doors in untapped areas. The NJCBA's 2025 market analysis projected that full statewide opt-in could support 400-500 dispensaries based on population density and consumer demand, suggesting the current market operates at 40-50% of potential capacity.

Tax Revenue Distribution and Municipal Budgets

The 2% local transfer tax authorized under N.J.S.A. 24:6I-36 has generated $41 million in municipal revenue since adult-use sales began in April 2022 through March 2026. This revenue is unevenly distributed: Jersey City collected $4.2 million in FY2025, while smaller municipalities with single dispensaries collected $300,000-$800,000. For mid-sized towns, cannabis tax revenue represents 1-3% of total municipal budgets, funding road repairs, park improvements, and in some cases, property tax relief.

This revenue disparity has created political pressure in neighboring municipalities. In Monmouth County, Long Branch's $1.8 million in cannabis tax revenue in 2025 prompted Eatontown and West Long Branch to reconsider their bans, with both towns passing enabling ordinances in late 2025. Similar dynamics have played out in Morris County, where Morristown's cannabis revenue prompted Parsippany-Troy Hills to opt in after three years of prohibition.

Wholesale Pricing and Supply Chain Impacts

Municipal cultivation bans have constrained supply, contributing to wholesale price volatility. As of May 2026, wholesale cannabis flower in New Jersey averaged $2,400 per pound, 35% above the national average of $1,780. Only 89 cultivation licenses have been issued statewide, with cultivation facilities concentrated in 41 municipalities, primarily in South Jersey agricultural areas and North Jersey industrial zones. This supply constraint has benefited vertically integrated operators with cultivation, manufacturing, and retail licenses, while disadvantaging retail-only operators dependent on wholesale markets.

Municipal control over distribution facilities has created additional bottlenecks. Distribution licenses, required for transporting cannabis between facilities, are limited to 52 statewide as of May 2026, with distributors facing municipal approval challenges similar to dispensaries. Some municipalities permit retail but prohibit distribution, forcing operators to route products through neighboring towns and adding transportation costs.

What Experts Say

According to Dianna Houenou, former chair of the New Jersey Cannabis Regulatory Commission, municipal control reflects a deliberate policy choice to balance statewide legalization with local autonomy. In a February 2025 interview with NJ Cannabis Insider, Houenou stated that the opt-in framework "respects New Jersey's home rule tradition while ensuring that municipalities cannot criminalize personal use," and noted that the Commission has "limited tools to compel local action" under CREAMMA's structure.

Edmund DeVeaux, president of the New Jersey CannaBusiness Association, has argued that the current system creates inefficiencies and inequities. In testimony before the Senate Economic Growth Committee in March 2026, DeVeaux said the association supports "reasonable municipal input" but believes "18-month approval timelines and inconsistent hearing procedures harm patients, operators, and municipalities that lose tax revenue to neighbors." DeVeaux has proposed legislative reforms including 90-day approval deadlines and standardized hearing requirements.

Michael Cerra, executive director of the New Jersey League of Municipalities, has defended local control as essential to responsive government. In a May 2026 op-ed in the Star-Ledger, Cerra wrote that municipalities "know their communities better than Trenton" and that "one-size-fits-all state mandates ignore the vast differences between Jersey City and rural Sussex County." Cerra has opposed proposals to limit municipal authority, arguing they would violate the compromise that enabled CREAMMA's passage.

Professor Robert Williams of Rutgers Law School, an expert on New Jersey constitutional law, has analyzed the tension between home rule and equal access. In a 2024 law review article, Williams wrote that while CREAMMA's opt-in framework is "constitutionally permissible," it creates "access inequities that may warrant legislative correction," particularly for medical patients. Williams suggested that the Legislature could require municipalities to permit medical dispensaries while preserving local control over adult-use retail, though he acknowledged such a distinction would face political and legal challenges.

What's Next: Calendar and Decision Points

The New Jersey Legislature is expected to consider municipal cannabis reforms during the 2026-2027 session, with multiple bills pending as of May 2026. A21/S21, introduced in March 2026, would require municipalities to act on cannabis applications within 120 days and establish a state-level appeals process for denials without written findings. The bill faces opposition from the League of Municipalities and has not advanced from committee as of mid-May 2026. A companion bill, A1847/S1092, would prohibit municipalities from banning medical dispensaries while preserving authority over adult-use retail; this bill has attracted bipartisan support and may advance in fall 2026.

The NJCRC is scheduled to release updated municipal guidance in June 2026, including model hearing procedures and recommended timelines. The guidance will be non-binding but may influence municipal practices, particularly in towns considering opt-in. The Commission has also proposed regulatory amendments, pending public comment through July 2026, that would require municipalities to specify approval timelines in their ordinances and prohibit conditional approvals that leave applicants in indefinite limbo.

Several municipalities are scheduled to vote on cannabis ordinances in summer 2026, including Montclair (considering expansion from retail to consumption lounges), Princeton (considering a second dispensary license), and Toms River (considering a medical-only opt-in). These votes will test whether the second wave of opt-ins continues or whether municipalities retrench in response to local opposition.

Litigation is also pending. In Ascend Wellness Holdings v. Township of Middletown, filed in Monmouth County Superior Court in April 2026, a dispensary applicant challenges the township's denial as arbitrary and capricious, arguing the council ignored favorable planning board recommendations and failed to provide written findings. A decision is expected in late 2026 and could establish precedent on the scope of judicial review for municipal cannabis denials.

Further Reading

• Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA), N.J.S.A. 24:6I-1 et seq. — https://www.njleg.state.nj.us/bill-search/2020/A21
• New Jersey Cannabis Regulatory Commission official website — https://www.nj.gov/cannabis/
• New Jersey Cannabis Regulatory Commission municipal toolkit — https://www.nj.gov/cannabis/businesses/local-government/
• New Jersey League of Municipalities cannabis resources — https://www.njlm.org/cannabis
• New Jersey CannaBusiness Association 2025 municipal approval study — https://www.njcannabusinessassociation.org/municipal-study
• Coalition for Medical Marijuana-New Jersey 2025 access equity report — https://www.cmmnj.org/access-report
• N.J.A.C. 17:30-7.2 (municipal approval requirements) — https://www.nj.gov/cannabis/rules/
• Open Public Meetings Act, N.J.S.A. 10:4-6 et seq. — https://www.nj.gov/dca/divisions/dlgs/resources/opma.html